Advertisement
Advertisement

China Insider

A pharmaceutical manufacturing line. Photo: Shutterstock

China Business

Can AI collaborations power China’s next wave of blockbuster drug deals?

China develops 30 per cent of new therapies worldwide as it rises to the top tier in innovation efficiency, drug supervision official says.

Exclusive | China challenges US in AI drug race, but rivals still reliant on each other

Citic Securities claims top spot in Asia-Pacific investment banking for 2025

China Business

China’s new drug insurance: lifeline for patients or squeeze on big firms?

New insurance formulary trims costs of Alzheimer’s and cancer therapies and marks a small win for global novel drug makers.

The commercial insurance formulary covers some medicines that are not yet eligible for reimbursement under the country’s National Reimbursement Drug List. Photo: Shutterstock
The commercial insurance formulary covers some medicines that are not yet eligible for reimbursement under the country’s National Reimbursement Drug List. Photo: Shutterstock

Banking & Finance

Yuan rapidly gaining ground as Chinese firms plot global expansion

Yuan’s use in cross-border payments rose 14 per cent year on year to 35 trillion yuan (US$4.9 trillion), according to the People’s Bank of China.

Banking & Finance

China’s market regulator appears in public after resignation report

The CSRC issued a statement and posted photos of Wu Qing in meetings hours after a report said he had sought to resign for health reasons.

Advertisement
Advertisement
Advertisement

China Business

Luxury and lifestyle giants signal confidence in China’s consumer recovery

L’Oréal and Lululemon lead a wave of foreign firms vowing fresh investment at Shanghai’s import expo, betting on a recovering luxury market.

The L’Oréal Group stand at the 8th China International Import Expo (CIIE) in Shanghai. Photo: AFP
The L’Oréal Group stand at the 8th China International Import Expo (CIIE) in Shanghai. Photo: AFP

Banking & Finance

Exclusive | Hong Kong’s financing future hinges on adapting to China’s hi-tech pivot: Huatai

To capitalise on the surge of hi-tech and biotech IPOs, Hong Kong introduced a slew of measures to speed up the listing process.

Banking & Finance

Global giants pivot investments to China’s new-economy sectors: HSBC co-CEO

Global firms are ‘positioning China as a global market for driving innovation, consumption and growth’, HSBC co-CEO David Liao says.

Business

Akeso shares slump despite second China approval for lung cancer drug

Chinese regulator grants second approval for lung cancer drug ivonescimab, which has outperformed Merck’s Keytruda in phase three trial.

Akeso’s new immunotherapy drug called ivonescimab allowed half of its patients to go 11.1 months without their condition worsening. Photo: Shutterstock

China Business

Trump’s tariffs: will Chinese pharmaceutical industry feel the pain?

With biotech firms caught in the crosshairs of Trump’s tariffs, the levy could prove to be a boon for domestic producers but a bane for exporters.

videocam
6
Employees of Jiangxi Banbiantian Pharmaceutical pack medicines at the company’s plant in Jiangxi province. Photo: VCG via Getty Images
Employees of Jiangxi Banbiantian Pharmaceutical pack medicines at the company’s plant in Jiangxi province. Photo: VCG via Getty Images

United States & Canada

US demands EU antitrust chief clarify rules reining in Big Tech

US lawmaker demands EU antitrust chief clarify how the Digital Markets Act targets US tech giants.

4

China Business

Shanghai aims for China’s carmaking crown with Toyota plant

The Japanese carmaker plans to tap the local supply chain, logistics network and talent pool to produce Lexus-branded EVs from 2027.

videocam

Hong Kong

HK Express pulls 2 blind people from flight, Hong Kong campaign group urges inquiry

Travellers, 34 and 27, ordered off plane before take-off for Tokyo, told by crew member they could not fly for ‘safety reasons’.

14
HK Express apologised to the passengers but defended the decision made by their crew as being “entirely based on safety considerations”. Photo: HK Express

China Business

Swire to turn Zhangyuan’s shikumen into Shanghai’s Covent Garden

Zhangyuan biggest draw is its 43 blocks of shikumen buildings, the Shanghai architectural style that blended Western style with Chinese aesthetics.

A cluster of traditional shikumen buildings sitting in the middle of Shanghai’s most famous shopping street Nanjing Road West, where Swire Properties and Jing’an Real Estate Group will open a high-end retail-residential-art complex in the rejuvenated century-old Zhangyuan. Photo: Swire Properties
A cluster of traditional shikumen buildings sitting in the middle of Shanghai’s most famous shopping street Nanjing Road West, where Swire Properties and Jing’an Real Estate Group will open a high-end retail-residential-art complex in the rejuvenated century-old Zhangyuan. Photo: Swire Properties

Policy

China to punish unauthorised data sharing with overseas law enforcement

Clause will fine Chinese companies for sharing data without permission but also shields them from foreign pressure.

13

Companies

Exclusive | China’s global asset shoppers brace for haircuts in forced fire sales

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
OPINION
Jane Lee

Opinion | Why Hong Kong must be careful about cutting university funding

Jane Lee
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement